Leveraging large-scale multi-omics evidences to identify therapeutic targets from genome-wide association studies
Samuel Lessard(Target (United States)), Clément Chatelain, Kadri Reis(University of Tartu), Priit Palta(University of Tartu), Emanuele de Rinaldis(Target (United States)), Mathieu Beauvais(Sanofi (France)), Jennifer Sloane(Sanofi (United States)), Michael J. Chao, K. Klinger(Sanofi (France)), Khader Shameer(Target (United States)), FinnGen(Sanofi (France)), Deepak K. Rajpal(Research Triangle Park Foundation)
Cited by 14
Related Papers
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
Interplay between the human gut microbiome and host metabolism
|Nature Communications|2019|784
Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine
|Nature Genetics|2016|701